Logo for Biofrontera Inc

Biofrontera Investor Relations Material

Latest events

Logo for Biofrontera Inc

Q1 2024

Biofrontera
Logo for Biofrontera

Q1 2024

16 May, 2024
Logo for Biofrontera

Q4 2023

18 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Biofrontera Inc

Access all reports
Biofrontera Inc. is a biopharmaceutical company based in the United States, engaged in the commercialization of pharmaceutical products designed to treat dermatological conditions. The company's focus is on photodynamic therapy (PDT) and topical antibiotics. Biofrontera's product portfolio includes Ameluz, a prescription drug for the treatment of actinic keratosis, a common precancerous skin condition, when used in combination with its BF-RhodoLED lamp. Another product, Xepi, is a topical cream approved for the treatment of impetigo, a bacterial skin infection. The company is headquartered in Woburn, Massachusetts, and its shares are listed on the Nasdaq.